Neurocrine Biosciences, Inc. with ticker code (NBIX) now have 24 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between 150 and 91 suggesting an average Analsyt target price of $124.67. Given that the stocks previous close was at $98.15 this now indicates there is a potential upside of 27.0%. It’s also worth noting that there is a 50 day moving average of $99.39 and the 200 day moving average is $107.73. The company has a market cap of 9.20B. The current share price for the company is: 94.33 USD
The potential market cap would be $11,691,202,239 based on the market consensus.
USD
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 154.64, revenue per share of 16.61 and a 7.65% return on assets.
